Step Promotion for Osteoarthritis
(STOP Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Adaptive Daily Step Promotion for osteoarthritis?
Research shows that a treatment approach called behavioural graded activity, which encourages gradual increases in physical activity, leads to better exercise adherence and more physical activity in people with osteoarthritis compared to usual care. This suggests that promoting daily steps could be effective for managing osteoarthritis.12345
How does the Step Promotion treatment for osteoarthritis differ from other treatments?
The Step Promotion treatment for osteoarthritis is unique because it uses a smartphone app to set adaptive step goals and rewards, encouraging increased physical activity through walking. This approach is different from traditional treatments as it focuses on behavior change and personalized goals to improve mobility and health.678910
What is the purpose of this trial?
Optimal knee joint loading, which refers to the forces acting on the knee caused by daily activities such as daily steps, plays an essential role in maintaining knee articular cartilage health and reducing the risk of osteoarthritis (OA). After anterior cruciate ligament reconstruction (ACLR), individuals take fewer daily steps as compared to uninjured controls resulting in insufficient knee joint loading to joint tissues, but it is unclear how changes in daily steps impact knee joint cartilage health in OA development. Therefore, the overall single arm, longitudinal pre-test post-test study objective is to determine the mechanistic links between knee joint loading as measured by daily steps and comprehensive magnetic resonance imaging (MRI) measures of knee joint cartilage health post-ACLR. The central hypothesis is that individuals post-ACLR who take low daily steps will demonstrate deconditioned, less resilient cartilage characterized by poor tibiofemoral cartilage composition and greater cartilage strain.
Research Team
Caroline Lisee, PhD
Principal Investigator
University of Georgia
Eligibility Criteria
This trial is for individuals who had ACL reconstruction surgery 6-24 months ago, are finished with physical therapy, can do unrestricted activities, and take fewer than 7,000 steps daily. They must own a smartphone and not plan to start any new knee therapies during the study. It's not for those with previous ACL graft injuries or other joint diseases in the knees, pregnant women or those planning pregnancy soon, people with BMI ≥ 36 kg/m2, non-English speakers, or certain medical conditions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo baseline assessment including MRI and physical activity monitoring
Intervention
Participants engage in a 16-week daily step promotion intervention to increase daily steps
Post-Intervention Assessment
Participants undergo post-intervention assessment including MRI and physical activity monitoring
Follow-up
Participants are monitored for safety and effectiveness after the intervention
Treatment Details
Interventions
- Adaptive Daily Step Promotion
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Georgia
Lead Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborator